Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2020 | 03-2019 | 03-2018 | |
| Sales | 199 | 0 | 0 |
| Operating Expenses | 5,603 | 4,372 | 3,767 |
| Operating Income | -5,404 | -4,372 | -3,767 |
| Other Income | -12 | 41 | -209 |
| Pre-tax Income | -5,416 | -4,331 | -3,976 |
| Net Income Continuous | -5,416 | -4,331 | -3,976 |
| Net Income | $-5,416 | $-4,331 | $-3,976 |
| EPS Basic Total Ops | -0.16 | -0.13 | -0.12 |
| EPS Basic Continuous Ops | -0.16 | N/A | N/A |
| EPS Diluted Total Ops | -0.16 | -0.13 | -0.12 |
| EPS Diluted Continuous Ops | -0.16 | N/A | N/A |
| EBITDA(a) | $-5,387 | $-4,352 | $-3,750 |